Osteopontin (OPN) has been associated with enhanced malignancy in breast cancer, but its functional role in this disease is poorly understood. To study the eect of OPN on cellular invasiveness, basal OPN expression was ®rst assessed in members of a progression series of human mammary epithelial cell lines (21PT: immortalized, non-tumorigenic; 21NT: weakly tumorigenic; 21MT-1: tumorigenic, weakly metastatic; MDA-MB-435 cells: tumorigenic, highly metastatic). The two lines which expressed lowest basal levels of OPN (21PT, 21NT) were then examined for up-regulation of invasive behavior in response to exogenous or transfected (endogenous) OPN. Both 21PT and 21NT showed increased invasiveness through Matrigel when human recombinant (hr)OPN was added to the lower chamber of transwells. Both also showed a cell migration response to hrOPN. Populations of 21PT and 21NT cells stably transfected with an OPN-expression vector showed higher levels of cell invasiness than control vector transfectants. Examination of transfectants for mRNA of a number of secreted proteases showed that only urokinase-type plasminogen activator (uPA) expression was closely associated with OPN expression and cellular invasiveness. Treatment of the parental 21PT and 21NT cells with exogenous hrOPN resulted in increased uPA mRNA expression and increased urokinase activity of the conditioned media. Both increased cell migration and induction of uPA expression are thus potential mechanisms of increased invasiness of breast epithelial cells in response to OPN.
Introduction
Osteopontin (OPN) is a secreted, integrin-binding glycophosphoprotein whose levels are increased in the primary tumors and plasma of patients with breast cancer (Brown et al., 1994; Hirota et al., 1995; BellahceÁ ne and Castronovo, 1995; Senger et al., 1988; Singhal et al., 1997; Tuck et al., 1998) . Our clinical studies have shown a relationship between plasma OPN, tumor burden, and prognosis in patients with metastatic breast cancer (Singhal et al., 1997) , as well as between tumor cell OPN and prognosis in patients with lymph node negative breast cancer (Tuck et al., 1998) .
In spite of these clinical associations, little is known regarding the biological role of OPN in the progression of human breast cancer. Studies have shown that OPN may be synthesized by tumor-in®ltrating macrophages (Brown et al., 1994; Hirota et al., 1995) and by breast cancer cells themselves (Senger et al., 1983; Morris et al., 1993; Bautista et al., 1994; Tuck et al., 1998) , although the relative biologic signi®cance of these dierent potential sources of OPN is not yet understood. Previous work (Xuan et al., , 1995 Senger and Perruzzi, 1996) has shown that some breast cancer cells show integrin-dependent adhesion to, and migratory response to OPN. Although these studies provide evidence that integrin binding is important in OPN-induced cell adhesion and chemotaxis of some mammary carcinoma cells, the functional signi®cance of these events in the progression and malignancy of breast cancer in general has yet to be determined.
Cellular invasiveness through the extracellular matrix is an aspect of cell behavior important during development, tissue remodeling, and malignancy. A role for OPN has been suggested in bone development and remodeling , and OPN has been shown to increase protease activity and invasiveness of osteoclastoma cells in culture (Teti et al., 1998) . Direct evidence for OPN involvement in cellular invasiveness in malignancy is lacking, although there are occasional reports of increased tumorigenicity and metastatic ability of rodent tumor cells with higher level expression of OPN (Oates et al., 1996; Chen et al., 1997) , and we and others have previously reported decreased tumorigencity upon down-regulating OPN expression of rodent tumor cells (Behrend et al., 1994; Feng et al., 1995; Gardner et al., 1994) .
To invade through extracellular matrix (ECM), cells must be able to digest the ECM components in order to clear a path, and then move through the matrix into the adjacent tissue. Increased invasiveness in response to OPN thus may be expected to be due to some combination of increased protease expression and/or increased cell movement. The ability of human breast carcinoma MDA-MB-435 cells to respond to OPN by directed cell migration has been previously described (Xuan et al., 1995; Senger and Perruzzi, 1996) . However, whether this is a general phenomenon for breast epithelial cells has not been established, and the issue of whether this can then be extended to increased invasiveness through ECM has not been addressed. Similarly, aside from a suggestion that OPN may induce increased secreted protease activity of osteoclastoma cells (Teti et al., 1998) , a direct in¯uence of OPN on protease expression has not been shown.
The purpose of the present work was to examine the ability of cultured human breast epithelial cells at dierent stages of progression to synthesize OPN, as well as to determine whether OPN can aect the invasiveness and protease expression of these cells. We have made use of the 21T series of human mammary epithelial cell lines (Band et al., 1990) , believed to represent dierent stages of tumor progression, in comparison with a highly metastatic human breast cancer cell line, MDA-MB-435 (Price et al., 1990) . Of the 21T series, 21PT cells are immortal but nontumorigenic, whereas 21NT are immortal and tumorigenic, but non-metastatic (Band et al., 1990) . MDA-MB-435 cells are both highly tumorigenic and metastatic in nude mice (Price et al., 1990) . Evidence is shown for the ability of all of these cells to synthesize OPN, with highest levels of expression in cells of greater malignancy. Evidence is also shown indicating that both non-tumorigenic (21PT) and tumorigenic (21NT) cell lines migrate towards OPN and invade through basement membrane in response to OPN. Upregulation of OPN expression by transfection with a constitutive high expression vector resulted in transfectant populations of both 21PT and 21NT cells which showed increased invasiveness through Matrigel. mRNA expression for a number of dierent secreted proteases was assessed in OPN-transfected cell populations. OPN transfectants showing increased invasiveness through Matrigel consistently showed up-regulation of urokinase-type plasminogen activator (uPA). Direct evidence for up-regulation of uPA (mRNA and enzyme activity) by OPN was obtained by treatment of the parental 21PT and 21NT cells with exogenous OPN.
Results

Osteopontin expression of 21T series cells vs MDA-MB-435 cells
OPN mRNA and protein expression were determined by Northern and Western analysis respectively, for 21T series cells (21PT, 21NT, 21MT-1) and MDA-MB-435 cells. Results of Northern analysis (Figure 1a) showed that all three parental 21T series cell lines express relatively low levels of OPN mRNA, compared to highly malignant, metastatic MDA-MB-435 cells. Assay of conditioned medium by Western analysis (Figure 1b) showed that the 21T series cell lines also secrete lower levels of OPN protein than MDA-MB-435 cells, with the highest levels of expression in the 21T series seen in the weakly metastatic MT-1 cells. The predominant form of secreted OPN seen in conditioned media of the 21T series cell lines was of high molecular weight (*97 kDa). This band was con®rmed as OPN by speci®c detection with anti-OPN polyclonal (rabbit anti-human) antibody as well (data not shown). In addition to the *97 kDa MW form, MDA-MB-435 cells also showed a signi®cant accumulation of lower molecular weight forms (including a major 66 kDa band) in the conditioned media. Examination of cell lysates by Western analysis (Figure 1c) showed that a major intracellular form of OPN present in all four cell lines was of 66 kDa MW. Again, highest levels of OPN protein were found in the metastatic (21MT-1 and MDA-MB-435) cells.
Invasion through Matrigel of parental 21PT and 21NT cells in response to exogenous (human recombinant) OPN As both 21PT (established, non-tumorigenic) and 21NT (tumorigenic, non-metastatic) cells express relatively low basal levels of OPN, these cells were examined further for altered invasiveness through Matrigel in response to exogenous human recombinant (hr)OPN. Invasive response of 21PT and 21NT to 100 mg/ml hrOPN is shown in Figure 2a . Both 21PT and 21NT cells showed low basal level of invasiveness The equivalent of 8 ± 10 mg of total secreted protein was loaded after correction for cell equivalents. (c) 20 mg of total cell lysate was loaded per lane, followed by fractionation in 8% SDS ± PAGE. Immunoblotting was performed as described in Materials and methods through Matrigel (21NT slightly greater than 21PT). Invasiveness of both cell lines was signi®cantly enhanced with hrOPN present in the lower chamber (21PT: P=0.0003, 21NT: P50.0001; Student's t-test). The hrOPN-induced invasiveness of 21NT was signi®cantly greater than that of 21PT (P=0.0001; Student's t-test).
Cell migration of 21PT and 21NT cells in response to hrOPN
One potential component of cellular invasive response to a chemoattractant is that of induced cell migration. Figure 2b shows the results of assay for the migratory response of parental 21PT and 21NT cells to exogenous hrOPN in the lower chamber of a transwell system, with or without the addition of 20 mg/ml of blocking anti-OPN monoclonal antibody (mAb53). Both 21PT and 21NT cells were found to respond to hrOPN by increased cell migration. This response was not signi®cantly altered by addition of non-speci®c mouse IgG to the lower chamber. On the other hand, complete blocking of hrOPN-induced cell migration of both 21PT and 21NT cells was seen when anti-OPN antibody was added to the lower chamber.`Criss-cross' assay has shown that the response to OPN is indeed directed (i.e. chemo/haptotaxis vs chemokinesis), and experiments using blocking GRGDS peptides and RGD-deletion mutant OPN have shown it to be RGD-dependent (data not shown).
Given the strong migration and invasion responsiveness of these cell lines to hrOPN when added to the culture media (`exogenous' OPN), we proceeded to establish stable transfectants of 21PT and 21NT which constitutively overexpress human OPN, in order to examine the in¯uence of native OPN produced by the cells themselves (`endogenous' OPN).
Transfection and screening of 21PT and 21NT cells
The OPN-containing expression vector, prepared as described in Materials and methods, was used in parallel with control experiments using the unmodified parental plasmid (pcDNA3) for LIPOFECTIN transfections (as described). Successful transfection of 21PT and 21NT cells was achieved, both with the OPNcontaining construct and the unmodi®ed pcDNA3 plasmid. Four pooled populations of G418-resistant OPN-transfected 21PT cells were obtained, designated PT/OPai, PT/OPaii, PT/OPbi and PT/OPbii. These consisted of combined harvesting of approximately 20, 25, 20 and 20 colonies, respectively. Two pools of Figure 2 (a) In vitro chemoinvasiveness of 21PT (PT) and 21NT (NT) cells in response to 100 mg/ml hrOPN (OP) in the lower chamber of 8 mm pore transwells, vs 0.1% BSA only (0). The ®lter of each transwell was coated with 35 mg Matrigel. Cells were seeded at 5610 4 cells/well in the upper chamber and incubated for 72 h, after which each ®lter was ®xed and stained, the upper surface wiped clean, and cells on the lower surface counted microscopically. Bar graphs represent the mean of counts (cells invaded/well) for three separate wells; error bars are s.e.m. Both 21PT and 21NT cells show signi®cantly increased invasion in response to hrOPN (P=0.0003, P50.0001 respectively; Student's t-test). 21NT shows signi®cantly greater hrOPN-induced invasiveness than 21PT (P=0.0001; Student's t-test). (b) Cell migration of 21PT (PT) and 21NT (NT) cells in transwell assay. Migration assays were performed as described in Materials and methods, with lower chamber contents as follows: 0.1% BSA alone (0); 50 mg/ml hrOPN alone (OP); 50 mg/ml hrOPN plus 20 mg/ml nonspeci®c IgG (OP+nIg); 50 mg/ml hrOPN plus 20 mg/ml anti-OPN antibody (aOPIg). Cells were seeded at 5610 4 cells/well in the upper chamber and incubated for 5 h, after which each ®lter was ®xed and stained, the upper surface wiped clean, and cells on the lower surface counted microscopically. The bar graphs represent the mean of four or ®ve counts from each of three separate wells and the error bars represent the standard error of the mean. Addition of anti-OPN antibody (but not non-speci®c IgG) signi®cantly reduced the OPN-induced migration of both 21PT (PT) and 21 (NT) cells (P50.05 for both, one-way ANOVA) G418-resistant vector-only control transfectants of 21PT cells were also obtained, designated PT/Ci and PT/Cii. These pools originated from combined harvesting of approximately 70 and 50 colonies, respectively. Similarly, four pools of G418-resistant OPN-transfected 21NT cells were obtained, designated NT/OPai, NT/OPaii, NT/OPbi and NT/OPbii, from combined harvesting of approximately 45, 25, 20 and 20 colonies, respectively. G418-resistant control transfectants of 21NT cells were obtained, designated as NT/Ci and NT/Cii. These consisted of combined harvesting of approximately 20 and 30 colonies respectively. From each of these pooled transfectant populations, 10 ± 15 clones were also isolated, expanded, and screened for OPN expression as described below.
OPN expression by the transfected cells was screened ®rst by assay of conditioned media using ELISA. Those OPN-transfected pools and clones of 21PT and 21NT cells expressing the highest levels of secreted OPN (by ELISA) are shown in Figure 3a , along with representative vector-only tranfected controls. Four OPN-transfected cell populations were thus chosen for further study; from 21PT cells, pooled population PT/OPaii and clone 12 derived from Pool PT/OPaii, designated PT/OPaiiC12; from 21NT cells, pooled population NT/OPbi and clone 4 derived from pool NT/OPaii, designated NT/OPaiiC4. Both pooled and cloned vector-control transfectant populations consistently showed levels of OPN expression by ELISA that were barely above background (BSA-only control), such that pools PT/Ci and NT/Ci were arbitrarily chosen for further comparative analysis. Conditioned media from these transfectant populations was then also examined by Western analysis, as shown in Figure  3b . The OPN-transfected cells (PT/OPaiiPool; PT/ OPaiiC12; NT/OPbiPool; NT/OPaiiC4) were found to secrete two major forms of OPN, migrating at about 66 kDa and 97 kDa, while vector-transfected controls (PT/Ci; NT/Ci) secreted low levels of OPN, predominantly of about 97 kDa.
Invasion through Matrigel of transfectants of 21PT and 21NT (vs MDA-MB-435) cells
Results of in vitro invasion assay for transfected cell populations of 21PT and 21NT (vs MDA-MB-435 cells) are shown in Figure 4 . Using a 35 mg/well membrane of Matrigel and a 72 h incubation, 21NT cells transfected with the control vector (NT/Ci) showed a basal level of invasion which was significantly greater than that of control vector-transfected 21PT (PT/Ci) cells. Interestingly, both pooled and cloned cell populations of OPN-transfected 21PT and 21NT cells (PT/OPaiiPool, PT/OPaiiC12; NT/OPbiPool, NT/OPaiiC4 respectively) showed signi®cantly increased invasiveness over that of the respective control cell population (P50.05 for all using Student's t-test). The fact that the pooled OPN-transfectant populations and control-vector transfectants examined represent an average of at least 20 ± 25 transfectant colonies/clones in each case, makes it highly unlikely that the dierences seen are due to random clonal variations. With regards to the clones examined, it is of interest that the cellular invasiveness of NT/OPaiiC4 cells was indeed found to approach that of the highly metastatic MDA-MB-435 control cell line.
Northern analysis for protease expression of OPN-transfected vs control 21PT and 21NT cells mRNA levels for a number of secreted proteases were examined in OPN-transfectant (PT/OPaiiPool, PT/ OPaiiC12; NT/OPbiPool, NT/OPaiiC4) and control vector transfectant (PT/Ci; NT/Ci) cell populations of A number of the secreted proteases showed dierences in expression between the control 21PT/Ci (non-tumorigenic) and 21NT/Ci (tumorigenic) cells. Cathepsins B, D and L, and MMP-9, all showed higher level expression in 21NT/Ci than 21PT/Ci. In contrast, both cell lines expressed MMP-2 at similar levels. However, none of the cathepsins or metalloproteinases studied showed a consistent relationship of level of expression with that of OPN.
Of all the secreted proteases examined, only uPA showed a close association of expression with that of OPN. Increased uPA mRNA was seen in all of the OPN-transfectants (of both 21PT and 21NT), at a level commensurate with the level of OPN. Similarly, MDA-MB-435 cells expressed high levels of both OPN and uPA mRNA. Level of OPN and uPA mRNA expression also showed association with invasive capacity in the transwell assay (c.f. Figure 4 ) (i.e. transfected cells expressing high levels of OPN also express high levels of uPA and invade better through Matrigel in transwell assays). uPA receptor (uPAR) expression was also examined, but was found to be expressed at comparable levels in control and OPNtransfected cells.
Induction of uPA mRNA and enzyme activity in 21PT and 21NT cells treated with exogenous hrOPN Incubation of the parental 21PT and 21NT cell lines with exogenous hrOPN (100 mg/ml), resulted in an increase in both uPA mRNA (as determined by Northern analysis, Figure 6a ) and in uPA enzyme activity in the conditioned media (as determined by Zymogram analysis, Figure 6b ). An increase in both uPA mRNA and enzyme activity for both cell lines was detected as early as 5 h post-induction. Incubation of the cells with hrOPN for longer periods showed that peak expression of uPA mRNA was seen for 21PT cells at 5 h whereas that for 21NT cells was at 18 h. For both cell lines, most of the increase in uPA enzyme activity of the conditioned media was seen over the ®rst 5 h, with only slight further accumulation with more prolonged incubations with hrOPN. The most dramatic increase in uPA enzyme activity was seen for 21PT cells, which showed lower basal (control) levels than 21NT cells.
Discussion
Although the secreted phosphoprotein OPN has been shown to be present in increased levels in the primary tumors and plasma of breast cancer patients (Brown et al., 1994; Hirota et al., 1995; BellahceÁ ne and Castronovo, 1995; Senger et al., 1988; Singhal et al., 1997; Tuck et al., 1998) , with levels in some instances associated with prognosis (Singhal et al., 1997; Tuck et al., 1998) , little is known about whether OPN functionally aects the malignancy of human breast carcinoma cells, and if so, by what mechanism. We have here undertaken to examine the ability of members of a progression series of breast epithelial cells (21T) (Band et al., 1990 ) (in comparison with the highly metastatic breast carcinoma cell line MDA-MB-435) to synthesize OPN, and to respond to OPN by increased invasiveness and protease expression.
Initial work to establish baseline levels of OPN mRNA and protein has shown that the 21T series cell lines, all of which are much less aggressive in nude mouse assays than MDA-MB-435 cells, as a group express lower levels of OPN (mRNA and protein) than MDA-MB-435 cells. Interestingly, assay of conditioned media by Western analysis has shown higher levels of OPN accumulation in cultures of cells known to be of greater in vivo malignancy (i.e. MDA-MB-435421MT-1421NT421PT). Furthermore, the predominant form of secreted OPN present in the conditioned media of the 21T series cell lines was of high molecular weight (*97 kDa), whereas MDA-MB-435 cells in addition show signi®cant accumulation of lower molecular weight forms (including a major 66 kDa band). The high molecular weight species may represent either a very heavily post-translationally modi®ed, or conjugated (by transglutaminase) form (Prince et al., 1991; Beninati et al., 1994; Sorensen et al., 1994; Sorensen and Petersen, 1995; Aeschlimann et al., 1996) . In keeping with this interpretation is our ®nding that the major intracellular form of OPN present in cell lysates (of both 21T series cells and MDA-MB-435 cells) is the low molecular weight, 66 kDa form. The relative biological activity of the dierent MW forms of OPN is at present largely unknown, although it has been suggested that transglutaminase crosslinking of extracellular matrix components may be important in stabilizing cellular adhesive contacts (Menter et al., 1991) , that sialylation and phosphorylation may modify OPN functions/activity (Shanmugam et al., 1997; Saavedra et al., 1995) , and that the thrombin cleavage fragment containing the GRGDS sequence is more eective at promoting haptotaxis (Senger and Perruzzi, 1996) .
The ®nding that both 21PT and 21NT cells respond to exogenously added hrOPN by increased invasion through Matrigel indicates that this responsiveness is not an exclusive property of tumorigenic (or more malignant) cells. Constitutive, high level expression of transfected OPN similarly was associated with increased invasiveness of both 21PT and 21NT transfectants. Thus, even at the earliest stage of tumor progression (established, non-tumorigenic 21PT cells), breast epithelial cells are capable of responding to OPN (either recombinant or transfected native OPN) by increased invasiveness through basement membrane. It would appear then, that the presence of OPN could thus in¯uence malignancy even at quite early stages of progression and that the dierences in in vivo malignant behavior of the 21T series cells and MDA-MB-435 cells may be related in part to their relative ability to independently express OPN, or to their relative anity for OPN. Studies presented here further indicate that induced cell migratory behavior (chemo/ haptotaxis) is a likely component of the increased invasiveness in response to OPN. This is in keeping with previous work of our own (Xuan et al., , 1995 , and of others (Senger and Perruzzi, 1996) , showing that MDA-MB-435 cells respond to OPN or cleavage fragments of OPN by increased chemohaptotactic activity. The cell migration response of 21T series cells to OPN has also been found to be directed (by`criss-cross' assay, not shown), speci®c (blocked by OPN-speci®c antibody and not nonspeci®c IgG), and RGD-dependent (data not shown), as is that of MDA-MB-435 cells. In some cell types (e.g. osteoclasts), there is evidence that OPN may modulate signal transduction pathways involving phosphatidylinositol 3-hydroxyl kinase and c-src, which may in turn be involved in regulating alterations in cell shape associated with cell movement (Chellaiah and Hruska, 1996; Hruska et al., 1995) .
In addition to the ability to move over an extracellular matrix, cells must be able to digest components of that matrix in order to invade. In the case of transfected OPN, the increase in cellular invasiveness was accompanied by increased expression of uPA. More direct evidence for up-regulation of uPA mRNA and enzyme activity by OPN has also been demonstrated here, in the experiments involving incubation of the 21PT and 21NT parental cell lines with exogenous hrOPN. uPA in turn is known to activate a variety of proteases (either directly or indirectly by activating plasminogen) (e.g. pro-MMP-1, -2, -3, -9, -14) (Baricos et al., 1995; Mazzieri et al., 1997; Werb, 1997) which are capable of digesting various components of the ECM (e.g. ®bronectin, tenascin, laminin, proteoglycans) (reviewed in Werb, 1997) , as well as activating certain growth factors (e.g. HGF, TGF-b, bFGF) (reviewed in Werb, 1997; Andreasen et al., 1997) , some of which may also be involved in cell migration and invasion (e.g. HGF). Thus, through triggering of a proteolytic cascade, with the ensuing modi®cation of ECM components including OPN, invading cells expressing uPA are capable not only of clearing a path of migration, but of continuously modifying their environment. In addition, it has been found that uPA/uPAR complexes bind vitronectin (which in turn binds to the same av integrins as osteopontin), and that uPAR may itself physically associate with certain integrins, such that some have suggested that uPA may stimulate cell migration and invasion by non-proteolytic mechanisms as well (e.g. by modulating adhesion interactions at focal contacts, or by triggering signal transduction pathways involved in the motility response) (Andreasen et al., 1997; Yebra et al., 1996) .
The ®nding that human breast epithelial cells upregulated for OPN expression are more invasive and express elevated levels of uPA lends functional signi®cance to clinical evidence that high level expression of both OPN and uPA (and uPAR) have been shown to be associated with poor prognosis in breast cancer (e.g. Singhal et al., 1997; Tuck et al., 1998; Andreasen et al., 1997 (review) ). It would appear from our work that the ability of breast epithelial cells to show increased invasiveness in response to OPN (with associated increased uPA expression) may be present even at early stages of progression (non-tumorigenic, non-metastatic 21PT cells), such that the availability of OPN in the microenvironment, or relative anity for OPN may be critical. In this light, the ability of a tumor cell to synthesize its own OPN would be expected to aord a distinct selective advantage, allowing for increased migratory ability and invasive growth, presumably with increased propensity for metastasis. Indeed, evidence from rodent models has recently shown that increasing OPN expression in a previously benign rat mammary epithelial cell line (Rama 37) is sucient to confer a metastatic phenotype on these cells (Oates et al., 1996; Chen et al., 1997) . Our ®nding that OPN, when either supplied to or produced by breast epithelial cells, is associated with both increased invasive behavior and expression of uPA, suggests a functional mechanism by which OPN may contribute to the malignancy of breast tumors.
Materials and methods
Cell lines and culture
The 21T series cell lines (21PT, 21NT, 21MT-1) were obtained as a kind gift of Dr Vimla Band (Dana Farber Cancer Institute) (Band et al., 1990) . These cells were maintained in culture in a-MEM supplemented with 10% FCS, 2 mM L-glutamine (all from GIBCO ± BRL/Life Technologies, Grand Island, NY, USA), insulin (1 mg/ml), epidermal growth factor [EGF] (12.5 ng/ml), hydrocortisone (2.8 mM), 10 mM HEPES, 1 mM sodium pyruvate, 0.1 mM nonessential amino acids, and 50 mg/ml gentamycin (all from Sigma Chemical, St. Louis, MO, USA) (aHE medium). MDA-MB-435 cells were obtained as a kind gift of Dr Janet Price (MD Anderson Cancer Center, Houston, TX, USA), and were grown in a MEM with 10% FCS (both from GIBCO ± BRL/Life Technologies).
RNA isolation and Northern blot analysis
Cell pellets from subcon¯uent monolayers were mechanically homogenized (Polytron PT 1200, Brinkman Instruments (Canada) Ltd., Mississauga, ON, Canada) and RNA extracted using TRIzol Reagent (Canadian Life Technologies Inc., Burlington, ON, Canada), according to the protocol supplied by the manufacturer. RNA (10 mg/lane) was run on a 1.1% agarose gel with 6.8% formaldehyde, and capillarytransferred to GeneScreen Plus ®lters (DuPont Canada Inc., Mississauga, ON, Canada). Blots were probed either with denatured, oligolabeled 32 P-dCTP cDNA probes (labeled using a kit provided by Pharmacia, Baie d'Urfe, PQ, Canada), or with 5'g 32 P-ATP end-labeled oligomers (labeled using a kit provided by Oncogene Science, Manhasset NY, USA), according to the procedures provided by the manufacturers, and as previously described (Tuck et al., 1990 (Tuck et al., , 1991 .
The OPN probe used was the full-length (1493 bp) human OPN cDNA EcoRI cassette of plasmid OP-10 (Young et al., 1990) . Probes for human proteinase and uPAR genes included: MMP-9 (92 kDa Type IV collagenase) (1046 bp insert from plasmid p92MO1) (gift of Dr WG StetlerStevenson), MMP-2 (72 kDa Type IV collagenase) (1117 bp insert from plasmid p3Ha) (Reponen et al., 1992) , cathepsin B (1.6 kb KpnI insert from plasmid pLC343) (gift of Dr B Sloane) (Cao et al., 1994) , cathepsin D (20 kb insert from plasmid pM13mp10) (gift of Dr H Rochefort) (Augereau et al., 1988) , cathepsin L (800 bp insert from plasmid pHCL800.1) (gift of Dr DT Denhardt) (Joseph et al., 1988) , urokinase-type plasminogen activator (40mer antisense oligonucleotide derived from the translated sequences of exon 4) (Calbiochem/Cederlane Laboratories, Hornby, Ontario, Canada, Cat#ON333) (Riccio et al., 1985) , urokinase-type plasminogen activator receptor (45mer antisense oligonucleotide probe to the ®rst 15 amino acids (not including the signal peptide) (Roldan et al., 1990) . Even loading of lanes was con®rmed by probing blots with a human 18S rRNA probe (p100D9; a kind gift from Dr DT Denhardt).
Western blotting of cell lysates and conditioned media
Cell lysates were prepared from cell cultures (grown to 70 ± 80% con¯uency on 100 mm dishes) by washing each culture dish twice with cold phosphate buered saline, followed by the addition of 500 ml cold lysis buer (20 mM HEPES pH 7.2, 5 mM MgCl 2 , 1% NP-40, 1 mM DTT, 2 mM PMSF, 4 mg/ml leupeptin, 4 mg/ml aprotinin). Each cell lysate was scraped from the dish, pipetted up and down to complete lysis, and spun at 16 000 g for 10 min to remove insoluble material. Each supernatant was collected and total protein concentration determined by Peterson's modi®cation of the standard Lowry assay (Peterson, 1977) . Twenty mg of total protein from each cell lysate was used for SDS ± PAGE gel electrophoresis and immunoblotting as described below.
Conditioned media were prepared by plating cells at 5610 5 cell/100 mm plate in regular growth medium and incubating overnight (18 h) at 378C, 5% CO 2 . Medium was then removed, and plates were washed X1 with warm, sterile PBS, and X2 with serum-free OPTI-MEM (GIBCO ± BRL/ Life Technologies). Serum-free OPTI-MEM was then added at 3 mls/100 mm plate, and plates were incubated 24 h at 378C, 5% CO 2 . Following the incubation period, the conditioned medium from each plate was collected, and the cell debris spun out. The supernatant was concentrated by ultra®ltration in Centricon-30 mini-concentrators as per the manufacturer's protocol (Amicon Inc., Beverly, MA, USA). Each corresponding plate was trypsinized, and a cell count performed, to allow appropriate correction in loading for cell equivalents.
Protein gel electrophoresis was done by standard SDS ± PAGE methods (Sambrook et al., 1989) , and immunoblotting by the enhanced chemiluminescence system (Amersham Canada, Oakville, ON, Canada). Cell lysates or conditioned media were fractionated on a denaturing SDS ± PAGE gel (8% for cell lysates, 12% for conditioned media), electrophoretically transferred to nylon membrane using a semi-dry system (Millipore Canada, Mississauga, ON, Canada), and detected with biotinylated monoclonal antibody mAb53 (0.2 mg/ml) (raised against human recombinant OPN), (Bautista et al., 1994) , followed by streptavidin-horseradish peroxidase conjugate (Jackson Immunological Laboratories). The enhanced chemiluminescence detection system (Amersham Corp.) was used to detect immune-reactive bands. Film exposure time was 20 s. Molecular mass markers used were biotinylated protein standards (Bio-Rad Laboratories, Hercules, CA, USA).
Transfections
An expression vector for use in transfection was generated by cloning the full-length human OPN cDNA (from plasmid OP-10, (Young et al., 1990) into plasmid pcDNA3 (Invitrogen Corp., San Diego, CA, USA) at the multiple cloning site between the strong, constitutive CMV immediate early gene enhancer-promoter and the (bovine) growth hormone polyadenylation and transcriptional termination signal sequences (between NotI and ApaI sites). This plasmid also contains the neomycin resistance gene, allowing for selection of stable transfectants in G418-containing medium. The control plasmid used for`vector-only' transfections consisted of the unmodi®ed pcDNA3 plasmid. Transfections were performed using the LIPOFECTIN reagent and the procedure described by the manufacturer (GIBCO ± BRL/Life Technologies), using 2 mg plasmid DNA for every 100 ml of OPTI-MEM I in Solution A, and 10 ml LIPOFECTIN reagent for every 100 ml of OPTI-MEM I in Solution B. Following a 48 h recovery period, transfected cells were subcultured into aHE medium containing 200 mg/ml (active) G418 (GIBCO ± BRL/Life Technologies) in order to select out stable transfectants. Plates were incubated until discrete colonies had developed, at which time both pooled populations and cloned transfectants were isolated for expansion in culture and further analysis. Conditioned medium was prepared for each transfectant population (essentially as described above, but without the need for Centricon concentration) for initial screening by ELISA assay for OPN expression. Those transfectant pooled and cloned populations expressing the highest level of OPN were then chosen for expansion and preparation of RNA, cytosolic protein, and secreted protein (conditioned media).
ELISA for OPN protein expression by transfected cell populations
Initial screening of transfectants for OPN protein expression was performed by ELISA of conditioned medium, essentially as described previously for plasma (Bautista et al., 1996; Singhal et al., 1997) . This is a capture ELISA based on high anity mouse monoclonal (Bautista et al., 1994) and rabbit polyclonal antibodies developed against a recombinant human OPN-GST fusion protein (GST-hOPN) that recognize native human OPN. Maxisorp immunoplates (GIBCO ± BRL/Life Technologies) were coated with mouse monoclonal anti-OPN antibody mAb53 (100 ml/well, 10 mg/ml), then blocked with 1% BSA in ST buer (0.15 M NaCl, 0.01 M Tris pH 8.0) with 0.05% Tween 20 (Bio-Rad). The wells were extensively washed with the STTween 20 buer prior to loading 100 ml of conditioned medium at various dilutions in ST-Tween 20 buer +1% BSA. The samples were incubated for 2 h at 48C for the primary antigen capture step. Sequential incubations at 378C of 100 ml followed by washing were performed with: (a) rabbit anti-OPN antibodies (0.8 mg/ml); (b) biotinylated goat anti-rabbit IgG (1 : 2000 dilution, Jackson Immunological Laboratories, Inc., West Grove, PA, USA). After washing, streptavidin conjugated alkaline phosphatase (1 : 2000, Jackson Immunological Laboratories Inc.) was added for 30 min at 378C. The wells were washed with buer and 100 ml of p-nitrophenyl phosphate (1 mg/ml in 100 mM Tris pH 9.5, 100 mM NaCl and 5 mM MgCl 2 ) was added and the signal was allowed to develop at room temperature over 4 ± 6 min. The reaction was stopped with 50 ml of 0.2 M Na 2 EDTA (pH 8.0). A Bio-Rad plate reader was used to quantify the color signal. Recombinant GST-hOPN fusion protein was used as standard, and background estimated by comparison against equivalent amounts of BSA protein. Internal controls of samples of known OPN concentration were used to normalize OPN values obtained from independent assays.
Cell invasion
In vitro invasiveness through Matrigel was assayed as described previously (Tuck et al., 1991) , using 24-well transwell chambers with polycarbonate ®lters of 8 mm pore size (Costar, Cambridge, MA, USA), coated with 35 mg Matrigel (Collaborative Research Inc., Bedford, MA, USA) per ®lter. The Matrigel concentration was determined by preliminary experiments using MDA-MB-435 cells and representative OPN-transfected 21T series cell lines. Matrigel was diluted to the desired ®nal concentration with cold, sterile, distilled water, applied to the ®lters, dried overnight in a tissue culture hood, and reconstituted the following morning with serum-free aHE medium. Cells for the assay were trypsinized and seeded to the upper chamber at 5610 4 cells per well in serum-free aHE medium containing 0.1% BSA. The lower chamber was ®lled with serum-free culture medium with 0.1% BSA and either 10 mg/ml ®bronectin (for assays involving transfectants) or 50 or 100 mg/ml hrOPN (for assays of parental (non-transfected) cell lines). Plates were incubated for 72 h in a 5% CO 2 incubator at 378C. Following incubation, the upper wells were removed and inverted, ®xed with 1% glutaraldehyde in phosphate-buered saline, stained with hematoxylin, dipped brie¯y in 1% ammonium hydroxide, and washed with water. The cells and Matrigel were then wiped o the upper surface of each ®lter with a cotton swab. After air-drying, cells from various areas of the lower surface of the ®lters were counted under 6100 magni®cation.
Cell migration
Cell migration assays were performed essentially as described previously (Xuan et al., 1995) , using 24-well transwell chambers with polycarbonate ®lters of 8 mm pore size (Costar, Cambridge, MA, USA). Gelatin (Sigma) was applied at 6 mg/®lter and air dried. The gelatin was rehydrated with 100 ml of serum-free aHE medium at room temperature for 90 min. Lower wells contained 800 ml of aHE plus 0.1% BSA, with or without test proteins. Cells (5610 4 ) were added to each upper well in aHE medium with 0.1% BSA and incubated at 378C; the time of incubation (5 h) for this series of cell lines was based on preliminary experiments in which optimal time for achieving countable numbers of all four parental cell lines was determined. At the end of the speci®ed incubation time, the cells that had migrated to the undersurface of the ®lters were ®xed in place with gluteraldehyde and stained with hematoxylin. Cells that had not migrated and were attached to the upper surface of the ®lters were removed from the ®lters with a cotton swab. The lower surfaces of the ®lters were examined microscopically under 1006 magni®cation and representative areas were counted to determine the number of cells that had migrated through the ®lters. The migratory response was tested in the presence or absence of blocking anti-OPN antibody in the lower chamber (20 mg/ml anti-OPN antibody, mAb53 (Bautista et al., 1994) ), in order to further assess the OPN speci®city of the response. Control experiments were also performed in which OPN blocking antibody in the lower chamber was replaced by non-immune mouse IgG at comparable concentration.
All cell migration and invasion assays were performed in triplicate. Statistical dierences between groups were assessed using the Mann-Whitney test, t-test, or ANOVA, using SigmaStat (Jandel Scienti®c, San Rafael, CA, USA) statistical software.
Induction of 21PT and 21NT cell uPA mRNA and enzyme activity by exogenous hrOPN 5610 5 cells/60 mm culture dish were seeded and kept overnight at 378C in medium with 10% FBS. The following morning, each plate was washed 36 with OPTI-MEM without serum. Plates were then incubated with 2 ml/plate of OPTI-MEM with or without 100 mg/ml hrOPN for the speci®ed time period. Conditioned media was then collected, and the cells trypsinized and counted. RNA extraction and Northern analysis were performed as described above.
Aliquots of conditioned medium were adjusted for cell number and diluted 1/50 for Zymogram analysis. The samples were separated by 11% SDS ± PAGE, the gel impregnated with 0.1% casein and 10 mg/ml plasminogen as previously described (Simon et al., 1996) . The gel was then incubated in 2.5% Triton-X 100 for 2 h, followed by incubation in 50 mM Tris (pH 8.3) and 0.1 M glycine for 18 h at 378C. The gel was ®xed in 15% acetic acid and stained with 0.25% Coomassie blue. Following destaining, plasminogen-dependent proteolysis was detected as a white band on a dark background.
